Our laboratory focuses on applied Alzheimer’s research, including drug development and drug repurposing to achieve new treatments for Alzheimer’s disease (AD), the most common cause of dementia. We plan to accomplish this by repurposing drugs from other disciplines for AD and through translational research and clinical trials. We use both bench to bedside and bedside to bench approaches.
We also plan to test innovative biomarkers (e.g. saliva and plasma) for diagnostic and screening purposes. There is strong interest in novel diagnostic tests but most of this interest is focused on amyloid and tau in spinal fluid. We want to explore other targets and other tissues.
Another goal of our research is to re-engineer the patient experience to be more decisive and more efficient with better outcomes. This includes testing and screening even before the patient visit.
Finally, we want to make meaningful and impactful contributions to the medical and scientific literature by collaborating with and mentoring medical students and neurology residents.
Active Research Projects
Marwan Sabbagh, MD, FAAN
Professor of Neurology
350 West Thomas Road
Phoenix, Arizona 85013
Barrow Neurologist Discusses Alzheimer’s Drug Trial Results
Barrow Neurologist Weighs in on Alzheimer’s Drug
Barrow Increasing Clinical Trials for Alzheimer’s Disease